Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
Most importantly, foreign reference pricing fails to address the real reasons Americans pay more for medicines than other countries: pharmacy benefit managers (PBMs), 340B hospital markups and foreign governments not paying their fair share for innovative medicines.
- Simplified Text
-
Foreign reference pricing fails to address reasons Americans pay more for medicines
- Confidence Score
- 0.900
- Claim Maker
- The author
- Context Type
- Blog
- Context Details
-
{ "policy_type": "Foreign reference pricing", "reasons_for_high_prices": [ "pharmacy benefit managers (PBMs)", "340B hospital markups", "foreign governments not paying their fair share" ] } - UUID
- 9fdb006a-09c1-46a8-b83a-4862f7bfaf0e
- Vector Index
- ✗ No vector
- Created
- September 11, 2025 at 10:25 PM (1 day ago)
- Last Updated
- September 11, 2025 at 10:25 PM (1 day ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
143
claims
🔥
1 day ago
https://phrma.org/
PhRMA highlights the importance of a robust innovation ecosystem for medical advancements. They emphasize concerns about government price setting and its potential negative impact on future cures.
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.